Glenn Irwin agrees a two-year deal with the PBM Ducati team to compete in the 2025 and 2026 British Superbike championships.

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

Glenn Irwin will remain with the PBM Racing Team for the next two Bennetts British Superbike Championship seasons. Irwin will ...

“You give me butterflies everyday... literally. Happy Birthday PBM,” he captioned his hard launch post. Elaine is a ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).

The matter is relevant to the pharmacies as GoodRx markets a prescription drug discount card that customers can use at ...

Three independent pharmacies have filed lawsuits accusing GoodRx, which markets a prescription drug discount card, of ...

Glenn Irwin has signed a new two-year deal with the PBM Ducati team for the 2025 and 2026 British Superbike Championship.

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator, GoodRx—to ...

Drug coupon aggregator GoodRx and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to ...